Lars Farde
Lars Farde
Professor of Psychiatry, Karolinska Institutet
Adresse e-mail validée de
Citée par
Citée par
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to …
L Farde, AL Nordström, FA Wiesel, S Pauli, C Halldin, G Sedvall
Archives of general psychiatry 49 (7), 538-544, 1992
Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET
L Farde, H Hall, E Ehrin, G Sedvall
Science 231 (4735), 258-261, 1986
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
L Farde, FA Wiesel, C Halldin, G Sedvall
Archives of general psychiatry 45 (1), 71-76, 1988
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
EG Jönsson, MM Nöthen, F Grünhage, L Farde, Y Nakashima, P Propping, ...
Molecular psychiatry 4 (3), 290-296, 1999
The correlative triad among aging, dopamine, and cognition: current status and future prospects
L Bäckman, L Nyberg, U Lindenberger, SC Li, L Farde
Neuroscience & Biobehavioral Reviews 30 (6), 791-807, 2006
Changes in cortical dopamine D1 receptor binding associated with cognitive training
F McNab, A Varrone, L Farde, A Jucaite, P Bystritsky, H Forssberg, ...
Science 323 (5915), 800-802, 2009
D2 dopamine receptors in neuroleptic-naive schizophrenic patients: a positron emission tomography study with [11C] raclopride
L Farde, FA Wiesel, S Stone-Elander, C Halldin, AL Nordström, HÅ Hall, ...
Archives of General Psychiatry 47 (3), 213-219, 1990
Age-related cognitive deficits mediated by changes in the striatal dopamine system
L Bäckman, N Ginovart, RA Dixon, TBR Wahlin, Å Wahlin, C Halldin, ...
American Journal of Psychiatry 157 (4), 635-637, 2000
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients
AL Nordström, L Farde, FA Wiesel, K Forslund, S Pauli, C Halldin, ...
Biological psychiatry 33 (4), 227-235, 1993
Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis
L Farde, L Eriksson, G Blomquist, C Halldin
Journal of Cerebral Blood Flow & Metabolism 9 (5), 696-708, 1989
Distribution of D 1-and D 2-dopamine receptors, and dopamine and its metabolites in the human brain
H Hall, G Sedvall, O Magnusson, J Kopp, C Halldin, L Farde
Neuropsychopharmacology 11 (4), 245-256, 1994
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients
AL Nordstrom, L Farde, S Nyberg, P Karlsson, C Halldin, G Sedvall
American Journal of Psychiatry 152 (10), 1444-1449, 1995
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
V Kaasinen, H Vilkman, J Hietala, K Någren, H Helenius, H Olsson, ...
Neurobiology of aging 21 (5), 683-688, 2000
D1-and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
L Farde, FA Wiesel, AL Nordström, G Sedvall
Psychopharmacology 99 (1), S28-S31, 1989
The serotonin system and spiritual experiences
J Borg, B Andrée, H Soderstrom, L Farde
American Journal of Psychiatry 160 (11), 1965-1969, 2003
No D2 receptor increase in PET study of schizophrenia
L Farde, FA Wiesel, HÅ Hall, C Halldin, S Stone-Elander, G Sedvall
Archives of General Psychiatry 44 (7), 671-672, 1987
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography
L Farde, E Ehrin, L Eriksson, T Greitz, H Hall, CG Hedström, JE Litton, ...
Proceedings of the National Academy of Sciences 82 (11), 3863-3867, 1985
PET analysis of human dopamine receptor subtypes using 11 C-SCH 23390 and 11 C-raclopride
L Farde, C Halldin, S Stone-Elander, G Sedvall
Psychopharmacology 92 (3), 278-284, 1987
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen
O Lindvall, EO Backlund, L Farde, G Sedvall, R Freedman, B Hoffer, ...
Annals of neurology 22 (4), 457-468, 1987
Suggested Minimal Effective Dose of Risperidone Based on PET-Measured D2 and 5-HT2A Receptor Occupancy in Schizophrenic Patients
S Nyberg, B Eriksson, G Oxenstierna, C Halldin, L Farde
American Journal of Psychiatry 156 (6), 869-875, 1999
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20